<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This article comments on the recent classifications of <z:hpo ids='HP_0001638'>cardiomyopathies</z:hpo> by the American Heart Association and the European Society of Cardiology with respect to their clinical applicability </plain></SENT>
<SENT sid="1" pm="."><plain>Taking them and the statement on the role of endomyocardial biopsies in different clinical scenarios together, the clinician is now able to identify genetic, autoimmune, and <z:mp ids='MP_0001799'>viral</z:mp> causative factors by using a thorough and logical approach to reach a diagnosis in patients with familial and nonfamilial forms of the underlying structural heart muscle diseases </plain></SENT>
<SENT sid="2" pm="."><plain>In this overview, a special emphasis is also placed on the management of inflammatory and <z:mp ids='MP_0001799'>viral</z:mp> <z:hpo ids='HP_0001638'>cardiomyopathies</z:hpo> </plain></SENT>
</text></document>